Last reviewed · How we verify

Amlodipine 10

Boehringer Ingelheim · FDA-approved active Small molecule Quality 2/100

Amlodipine 10 is a Small molecule drug developed by Boehringer Ingelheim. It is currently FDA-approved.

At a glance

Generic nameAmlodipine 10
SponsorBoehringer Ingelheim
ModalitySmall molecule
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Amlodipine 10

What is Amlodipine 10?

Amlodipine 10 is a Small molecule drug developed by Boehringer Ingelheim.

Who makes Amlodipine 10?

Amlodipine 10 is developed and marketed by Boehringer Ingelheim (see full Boehringer Ingelheim pipeline at /company/boehringer-ingelheim).

What development phase is Amlodipine 10 in?

Amlodipine 10 is FDA-approved (marketed).

Related

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing